Australia's most trusted
source of pharma news
Sunday, 26 October 2025
Posted 24 October 2025 PM
News that an Aussie expat was heading home for a new role and a very handsome remuneration package was our top story this week.
Former Baxter VP Bruce Peatey has been named the new CEO of Melbourne-based PolyNovo. He's been welcomed with open arms plus a salary of $600,000 plus super and a one-off grant of $600,000 worth of Alignment Share Appreciation Rights after a tenure of five years.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.